Targeted Protein Degradation: from Chemical Biology to Drug Discovery.

Cell chemical biology (2017-06-27)
Philipp M Cromm, Craig M Crews
摘要

Traditional pharmaceutical drug discovery is almost exclusively focused on directly controlling protein activity to cure diseases. Modulators of protein activity, especially inhibitors, are developed and applied at high concentration to achieve maximal effects. Thereby, reduced bioavailability and off-target effects can hamper compound efficacy. Nucleic acid-based strategies that control protein function by affecting expression have emerged as an alternative. However, metabolic stability and broad bioavailability represent development hurdles that remain to be overcome for these approaches. More recently, utilizing the cell's own protein destruction machinery for selective degradation of essential drivers of human disorders has opened up a new and exciting area of drug discovery. Small-molecule-induced proteolysis of selected substrates offers the potential of reaching beyond the limitations of the current pharmaceutical paradigm to expand the druggable target space.

材料
货号
品牌
产品描述

Sigma-Aldrich
(S,R,S)-VL285 Phenol-C3-piperazine hydrochloride
Sigma-Aldrich
(S,R,S)-VL285 Phenol-methylamino-PEG1-NH2 hydrochloride
Sigma-Aldrich
(S,R,S)-AHPC-pyrimidine-piperazine-PEG1-NH2 hydrochloride
Sigma-Aldrich
(S,R,S)-VL285 Phenol-C6-NH2 hydrochloride
Sigma-Aldrich
(S,R,S)-AHPC-pyridine-PEG1-piperazine hydrochloride
Sigma-Aldrich
(S,R,S)-VL285 Phenol-PEG2-NH2 hydrochloride
Sigma-Aldrich
C5 Lenalidomide-pyrimidine-piperazine-PEG1-NH2 hydrochloride, ≥95%
Sigma-Aldrich
C5 Lenalidomide-PEG6-Butyl NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-PEG3-NH2 hydrochloride, ≥95%
Sigma-Aldrich
(S,R,S)-AHPC-PEG1-NH2 hydrochloride, ≥95%
Sigma-Aldrich
(S,R,S)-AHPC-PEG2-butyl CO2H, ≥95%
Sigma-Aldrich
(S,R,S)-VL285 Phenol-PEG4-NH2 hydrochloride
Sigma-Aldrich
Pomalidomide-C3-CO2H, ≥95%
Sigma-Aldrich
(S,R,S)-VL285 Phenol-C2-NH2 hydrochloride
Sigma-Aldrich
(S,R,S)-VL285 Phenol-PEG1-piperazine hydrochloride
Sigma-Aldrich
(S,R,S)-AHPC-methylamino-PEG1-NH2 hydrochloride
Sigma-Aldrich
Pomalidomide-dipiperazine-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-PEG2-CO2H, 95%
Sigma-Aldrich
Pomalidomide-pyridine-PEG1-piperazine hydrochloride
Sigma-Aldrich
C5 Lenalidomide-pyridine-PEG1-piperazine hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-PEG2-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-PEG1-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-PEG1-CO2H, ≥95%
Sigma-Aldrich
C5 Lenalidomide-PEG1-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-benzyl-piperazine hydrochloride
Sigma-Aldrich
(S,R,S)-AHPC-benzyl-piperazine hydrochloride
Sigma-Aldrich
C5 Lenalidomide-benzyl-piperazine hydrochloride
Sigma-Aldrich
C5 Lenalidomide-PEG3-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-PEG4-CO2H
Sigma-Aldrich
(S,R,S)-AHPC-PEG5-NH2 hydrochloride

社交媒体

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

科研、开发、生产。

作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。

© 2021年版权归德国达姆施塔特默克集团(Merck KGaA)及/或其附属公司所有。版权所有。

未经许可,严禁复制本网站上的任何资料。